{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:51:19Z","timestamp":1790013079566,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["7051-00001A"],"award-info":[{"award-number":["7051-00001A"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF19OC0055353"],"award-info":[{"award-number":["NNF19OC0055353"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024075","name":"Region Syddanmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013814","name":"Klinisk Institut, Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-04037-z","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T14:56:45Z","timestamp":1731596205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical outcome is unlinked to injection of adipose-derived regenerative cells in the axilla of breast cancer-related lymphedema patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Ditte Caroline","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik Adam","family":"Bjerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads Gustaf","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Ahm","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9683-8761","authenticated-orcid":false,"given":"Charlotte Harken","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"4037_CR1","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1016\/j.clbc.2023.03.016","volume":"23","author":"MG Jorgensen","year":"2023","unstructured":"Jorgensen MG, Gozeri E, Petersen TG, Sorensen JA. Surgical-site infection is associated with increased risk of breast cancer-related lymphedema: a nationwide cohort study. Clin Breast Cancer. 2023;23:e296\u2013304. https:\/\/doi.org\/10.1016\/j.clbc.2023.03.016.","journal-title":"Clin Breast Cancer"},{"key":"4037_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.breast.2017.01.009","volume":"32","author":"NM Toyserkani","year":"2017","unstructured":"Toyserkani NM, Jorgensen MG, Haugaard K, Sorensen JA. Seroma indicates increased risk of lymphedema following breast cancer treatment: a retrospective cohort study. Breast. 2017;32:102\u20134. https:\/\/doi.org\/10.1016\/j.breast.2017.01.009.","journal-title":"Breast"},{"key":"4037_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071540","author":"MG Jorgensen","year":"2021","unstructured":"Jorgensen MG, Toyserkani NM, Hansen FCG, Thomsen JB, Sorensen JA. Prospective validation of indocyanine green lymphangiography staging of breast cancer-related lymphedema. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13071540.","journal-title":"Cancers"},{"key":"4037_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/caac.20001","volume":"59","author":"BD Lawenda","year":"2009","unstructured":"Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59:8\u201324. https:\/\/doi.org\/10.3322\/caac.20001.","journal-title":"CA Cancer J Clin"},{"key":"4037_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41523-021-00276-y","volume":"7","author":"MG Jorgensen","year":"2021","unstructured":"Jorgensen MG, Toyserkani NM, Hansen FG, Bygum A, Sorensen JA. The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment. NPJ Breast Cancer. 2021;7:70. https:\/\/doi.org\/10.1038\/s41523-021-00276-y.","journal-title":"NPJ Breast Cancer"},{"key":"4037_CR6","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.pmrj.2012.05.003","volume":"4","author":"BB Lasinski","year":"2012","unstructured":"Lasinski BB, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R. 2012;4:580\u2013601. https:\/\/doi.org\/10.1016\/j.pmrj.2012.05.003.","journal-title":"PM R"},{"key":"4037_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/2000656X.2020.1772799","volume":"54","author":"A Bucan","year":"2020","unstructured":"Bucan A, et al. Comparison between stromal vascular fraction and adipose derived stem cells in a mouse lymphedema model. J Plast Surg Hand Surg. 2020;54:302\u201311. https:\/\/doi.org\/10.1080\/2000656X.2020.1772799.","journal-title":"J Plast Surg Hand Surg"},{"key":"4037_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jso.25661","volume":"121","author":"CE Chen","year":"2020","unstructured":"Chen CE, Chiang NJ, Perng CK, Ma H, Lin CH. Review of preclinical and clinical studies of using cell-based therapy for secondary lymphedema. J Surg Oncol. 2020;121:109\u201320. https:\/\/doi.org\/10.1002\/jso.25661.","journal-title":"J Surg Oncol"},{"key":"4037_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/PRS.0000000000006474","volume":"145","author":"T Dai","year":"2020","unstructured":"Dai T, et al. The roles of podoplanin-positive\/podoplanin-negative cells from adipose-derived stem cells in lymphatic regeneration. Plast Reconstr Surg. 2020;145:420\u201331. https:\/\/doi.org\/10.1097\/PRS.0000000000006474.","journal-title":"Plast Reconstr Surg"},{"key":"4037_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/PRS.0000000000003110","volume":"139","author":"K Hayashida","year":"2017","unstructured":"Hayashida K, et al. Adipose-derived stem cells and vascularized lymph node transfers successfully treat mouse hindlimb secondary lymphedema by early reconnection of the lymphatic system and lymphangiogenesis. Plast Reconstr Surg. 2017;139:639\u201351. https:\/\/doi.org\/10.1097\/PRS.0000000000003110.","journal-title":"Plast Reconstr Surg"},{"key":"4037_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2217\/rme.15.24","volume":"10","author":"S Yoshida","year":"2015","unstructured":"Yoshida S, et al. Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model. Regen Med. 2015;10:549\u201362. https:\/\/doi.org\/10.2217\/rme.15.24.","journal-title":"Regen Med"},{"key":"4037_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.5966\/sctm.2015-0357","volume":"5","author":"NM Toyserkani","year":"2016","unstructured":"Toyserkani NM, Jensen CH, Sheikh SP, S\u00f8rensen JA. Cell-Assisted lipotransfer using autologous adipose-derived stromal cells for alleviation of breast cancer-related lymphedema. Stem Cells Transl Med. 2016;5:857\u20139. https:\/\/doi.org\/10.5966\/sctm.2015-0357.","journal-title":"Stem Cells Transl Med"},{"key":"4037_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/jjco\/hyn090","volume":"38","author":"C Hou","year":"2008","unstructured":"Hou C, Wu X, Jin X. Autologous bone marrow stromal cells transplantation for the treatment of secondary arm lymphedema: a prospective controlled study in patients with breast cancer related lymphedema. Jpn J Clin Oncol. 2008;38:670\u20134. https:\/\/doi.org\/10.1093\/jjco\/hyn090.","journal-title":"Jpn J Clin Oncol"},{"key":"4037_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1089\/lrb.2017.0027","volume":"16","author":"AM Ismail","year":"2018","unstructured":"Ismail AM, et al. Stem cell therapy using bone marrow-derived mononuclear cells in treatment of lower limb lymphedema: a randomized controlled clinical trial. Lymphat Res Biol. 2018;16:270\u20137. https:\/\/doi.org\/10.1089\/lrb.2017.0027.","journal-title":"Lymphat Res Biol"},{"key":"4037_CR15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/sctm.20-0394","volume":"10","author":"MG Jorgensen","year":"2021","unstructured":"Jorgensen MG, et al. Adipose-derived regenerative cells and lipotransfer in alleviating breast cancer-related lymphedema: an open-label phase I trial with 4 years of follow-up. Stem Cells Transl Med. 2021;10:844\u201354. https:\/\/doi.org\/10.1002\/sctm.20-0394.","journal-title":"Stem Cells Transl Med"},{"key":"4037_CR16","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3109\/14653249.2011.594791","volume":"13","author":"GE Maldonado","year":"2011","unstructured":"Maldonado GE, et al. Autologous stem cells for the treatment of post-mastectomy lymphedema: a pilot study. Cytotherapy. 2011;13:1249\u201355. https:\/\/doi.org\/10.3109\/14653249.2011.594791.","journal-title":"Cytotherapy"},{"key":"4037_CR17","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/sctm.17-0037","volume":"6","author":"NM Toyserkani","year":"2017","unstructured":"Toyserkani NM, Jensen CH, Andersen DC, Sheikh SP, Sorensen JA. Treatment of breast cancer-related lymphedema with adipose-derived regenerative cells and fat grafts: a feasibility and safety study. Stem Cells Transl Med. 2017;6:1666\u201372. https:\/\/doi.org\/10.1002\/sctm.17-0037.","journal-title":"Stem Cells Transl Med"},{"key":"4037_CR18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1186\/s13287-021-02632-y","volume":"12","author":"H Lafuente","year":"2021","unstructured":"Lafuente H, Jaunarena I, Ansuategui E, Lekuona A, Izeta A. Cell therapy as a treatment of secondary lymphedema: a systematic review and meta-analysis. Stem Cell Res Ther. 2021;12:578. https:\/\/doi.org\/10.1186\/s13287-021-02632-y.","journal-title":"Stem Cell Res Ther"},{"key":"4037_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000011343","author":"MG J\u00f8rgensen","year":"2021","unstructured":"J\u00f8rgensen MG, Jensen CH, Hermann AP, Andersen DC, Toyserkani NM, Sheikh SP, S\u00f8rensen JA. No Clinical Efficacy of adipose-derived regenerative cells and lipotransfer in breast cancer-related lymphedema: a double-blinded placebo-controlled phase-II trial. Plast Reconstr Surg. 2021. https:\/\/doi.org\/10.1097\/PRS.0000000000011343.","journal-title":"Plast Reconstr Surg"},{"key":"4037_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122761","volume":"351","author":"A Kostecka","year":"2024","unstructured":"Kostecka A, et al. Adipose-derived mesenchymal stromal cells in clinical trials: Insights from single-cell studies. Life Sci. 2024;351: 122761. https:\/\/doi.org\/10.1016\/j.lfs.2024.122761.","journal-title":"Life Sci"},{"key":"4037_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ebiom.2016.01.024","volume":"5","author":"MK Haahr","year":"2016","unstructured":"Haahr MK, et al. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine. 2016;5:204\u201310. https:\/\/doi.org\/10.1016\/j.ebiom.2016.01.024.","journal-title":"EBioMedicine"},{"key":"4037_CR22","doi-asserted-by":"publisher","DOI":"10.3791\/59183","author":"ST Hansen","year":"2021","unstructured":"Hansen ST, Jensen CH, S\u00f8rensen JA, Sheikh SP, Lund L. Isolation of Adipose derived regenerative cells for the treatment of erectile dysfunction following radical prostatectomy. J Vis Exp. 2021. https:\/\/doi.org\/10.3791\/59183.","journal-title":"J Vis Exp"},{"key":"4037_CR23","doi-asserted-by":"publisher","first-page":"14401","DOI":"10.1038\/s41598-023-41535-1","volume":"13","author":"P Dhumale","year":"2023","unstructured":"Dhumale P, et al. CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects. Sci Rep. 2023;13:14401. https:\/\/doi.org\/10.1038\/s41598-023-41535-1.","journal-title":"Sci Rep"},{"key":"4037_CR24","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419. https:\/\/doi.org\/10.1126\/science.1260419.","journal-title":"Science"},{"key":"4037_CR25","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;177:1888\u2013902. https:\/\/doi.org\/10.1016\/j.cell.2019.05.031.","journal-title":"Cell"},{"key":"4037_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.05.004","author":"CM Trigo","year":"2024","unstructured":"Trigo CM, Rodrigues JS, Camoes SP, Sola S, Miranda JP. Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? J Adv Res. 2024. https:\/\/doi.org\/10.1016\/j.jare.2024.05.004.","journal-title":"J Adv Res"},{"key":"4037_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12967-024-05294-5","volume":"22","author":"S Chen","year":"2024","unstructured":"Chen S, Liang B, Xu J. Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations. J Transl Med. 2024;22:459. https:\/\/doi.org\/10.1186\/s12967-024-05294-5.","journal-title":"J Transl Med"},{"key":"4037_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.5483\/BMBRep.2023-0161","volume":"57","author":"J Chun","year":"2024","unstructured":"Chun J, et al. Single-cell RNA sequencing reveals the heterogeneity of adipose tissue-derived mesenchymal stem cells under chondrogenic induction. BMB Rep. 2024;57:232\u20137. https:\/\/doi.org\/10.5483\/BMBRep.2023-0161.","journal-title":"BMB Rep"},{"key":"4037_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13287-024-03722-3","volume":"15","author":"G Maged","year":"2024","unstructured":"Maged G, Abdelsamed MA, Wang H, Lotfy A. The potency of mesenchymal stem\/stromal cells: does donor sex matter? Stem Cell Res Ther. 2024;15:112. https:\/\/doi.org\/10.1186\/s13287-024-03722-3.","journal-title":"Stem Cell Res Ther"},{"key":"4037_CR30","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41467-024-48914-w","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang H, et al. Single-cell analysis reveals a subpopulation of adipose progenitor cells that impairs glucose homeostasis. Nat Commun. 2024;15:4827. https:\/\/doi.org\/10.1038\/s41467-024-48914-w.","journal-title":"Nat Commun"},{"key":"4037_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12664-024-01524-2","volume":"43","author":"J Devi","year":"2024","unstructured":"Devi J, Ballard DH, Aswani-Omprakash T, Parian AM, Deepak P. Perianal fistulizing Crohn\u2019s disease: current perspectives on diagnosis, monitoring and management with a focus on emerging therapies. Indian J Gastroenterol. 2024;43:48\u201363. https:\/\/doi.org\/10.1007\/s12664-024-01524-2.","journal-title":"Indian J Gastroenterol"},{"key":"4037_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/JPD-181309","volume":"8","author":"S Polgar","year":"2018","unstructured":"Polgar S, Karimi L, Buultjens M, Morris ME, Busse M. Assessing the Efficacy of cell transplantation for Parkinson\u2019s Disease: a patient-centered approach. J Parkinsons Dis. 2018;8:375\u201383. https:\/\/doi.org\/10.3233\/JPD-181309.","journal-title":"J Parkinsons Dis"},{"key":"4037_CR33","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1038\/s41467-021-26152-8","volume":"12","author":"C Ziegenhain","year":"2021","unstructured":"Ziegenhain C, Sandberg R. BAMboozle removes genetic variation from human sequence data for open data sharing. Nat Commun. 2021;12:6216. https:\/\/doi.org\/10.1038\/s41467-021-26152-8.","journal-title":"Nat Commun"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04037-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-04037-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04037-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T15:05:44Z","timestamp":1731596744000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-04037-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4037"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-04037-z","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"3 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In the present study, we included samples obtained during the randomized placebo controlled trial entitled \u201cTreatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting\u201d (Clinical Trial.gov ID: NCT03776721) []. The study was approved December 7th, 2018 by The Regional Committees on Health Research Ethics for Southern Denmark (S-20180117) and registered with the Danish Data Protection Agency (18\/51767). All patients gave a written informed consent for participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The informed consent included a section regarding publication of study data and was signed by all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests. The authors also declare that they have not used Artificial Intelligence in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"426"}}